Lightspeed is in discussions to lead the funding round, sources say.
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
Lightspeed is in discussions to lead the funding round, sources say.
Lightspeed is in discussions to lead the funding round, sources say.
Lightspeed is in discussions to lead the funding round, sources say.